Neuropeptide Y in First-episode Schizophrenia: is There Any Sex Differences in the Pathogeneses of Schizophrenia?

Overview

Journal Front Psychiatry

Specialty Psychiatry

Date 2024 Dec 18

PMID 39691787

Authors

Jia-Qi Song

Wen Xin

Jian-Jin Yu

Qing Zhao

Hong-Na Li

Da-Chun Chen

Affiliations

Soon will be listed here.

Abstract

Objective: This study investigated relationships between Neuropeptide Y levels and severity of psychiatric symptoms in first-episode schizophrenia patients, and explore the sexual heterogeneity in them.

Methods: We recruited 115 first-episode schizophrenia patients and 58 matched healthy controls, and measured serum Neuropeptide Y levels of them at baseline and again after 10 weeks of risperidone treatment in patient group. Patients were also evaluated with the Positive and Negative Symptoms Scale (PANSS) to reveal the severity of symptoms.

Results: 95 patients completed the whole experiment. We find that mean Neuropeptide Y levels at baseline were significantly higher in patients than in controls (p<0.001), no matter in males or females. In males, there are positive correlations between Neuropeptide Y levels and PANSS scores at baseline (p<0.01), and between the change of them (p<0.05). However, we do not find these correlations in female patients. Furthermore, the interaction terms of NPY × sex were highly significant taking PANSS as dependent variable(p<0.001).

Conclusion: Neuropeptide Y plays a significant role in the pathogenesis of schizophrenia. In male patients, Neuropeptide Y is positively correlated with the severity of symptoms, while this correlation is not found in females. Continued efforts are needed to determine the sexual dimorphism in pathogeneses of schizophrenia.

References

Bjornebekk A, Mathe A, Gruber S, Brene S . Social isolation increases number of newly proliferated cells in hippocampus in female flinders sensitive line rats. Hippocampus. 2007; 17(12):1193-200. DOI: 10.1002/hipo.20352. View

Mellios N, Huang H, Baker S, Galdzicka M, Ginns E, Akbarian S . Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia. Biol Psychiatry. 2009; 65(12):1006-14. DOI: 10.1016/j.biopsych.2008.11.019. View

Karl T, Chesworth R, Duffy L, Herzog H . Acoustic startle response and sensorimotor gating in a genetic mouse model for the Y1 receptor. Neuropeptides. 2010; 44(3):233-9. DOI: 10.1016/j.npep.2009.12.008. View

Gotzsche C, Woldbye D . The role of NPY in learning and memory. Neuropeptides. 2015; 55:79-89. DOI: 10.1016/j.npep.2015.09.010. View

Meurs A, Portelli J, Clinckers R, Balasubramaniam A, Michotte Y, Smolders I . Neuropeptide Y increases in vivo hippocampal extracellular glutamate levels through Y1 receptor activation. Neurosci Lett. 2012; 510(2):143-7. DOI: 10.1016/j.neulet.2012.01.023. View

Peters J, VAN KAMMEN D, Gelernter J, Yao J, Shaw D . Neuropeptide Y-like immunoreactivity in schizophrenia. Relationships with clinical measures. Schizophr Res. 1990; 3(5-6):287-94. DOI: 10.1016/0920-9964(90)90012-v. View

Nahvi R, Sabban E . Sex Differences in the Neuropeptide Y System and Implications for Stress Related Disorders. Biomolecules. 2020; 10(9). PMC: 7564266. DOI: 10.3390/biom10091248. View

Inaba A, Komori Y, Muroi Y, Kinoshita K, Ishii T . Neuropeptide Y signaling in the dorsal raphe nucleus inhibits male sexual behavior in mice. Neuroscience. 2016; 320:140-8. DOI: 10.1016/j.neuroscience.2016.01.069. View

Acosta-Martinez M, Horton T, Levine J . Estrogen receptors in neuropeptide Y neurons: at the crossroads of feeding and reproduction. Trends Endocrinol Metab. 2006; 18(2):48-50. DOI: 10.1016/j.tem.2006.12.001. View

10.

Quarta D, Leslie C, Carletti R, Valerio E, Caberlotto L . Central administration of NPY or an NPY-Y5 selective agonist increase in vivo extracellular monoamine levels in mesocorticolimbic projecting areas. Neuropharmacology. 2010; 60(2-3):328-35. DOI: 10.1016/j.neuropharm.2010.09.016. View

11.

Lian J, Huang X, Pai N, Deng C . Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways. Psychoneuroendocrinology. 2014; 48:77-86. DOI: 10.1016/j.psyneuen.2014.06.010. View

12.

Ferno J, Varela L, Skrede S, Vazquez M, Nogueiras R, Dieguez C . Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation. PLoS One. 2011; 6(6):e20571. PMC: 3113797. DOI: 10.1371/journal.pone.0020571. View

13.

Ikeda K, Ikeda K, Iritani S, Ueno H, Niizato K . Distribution of neuropeptide Y interneurons in the dorsal prefrontal cortex of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2004; 28(2):379-83. DOI: 10.1016/j.pnpbp.2003.11.008. View

14.

Stalberg G, Ekselius L, Lindstrom L, Larhammar D, Boden R . Neuropeptide Y, social function and long-term outcome in schizophrenia. Schizophr Res. 2014; 156(2-3):223-7. DOI: 10.1016/j.schres.2014.04.006. View

15.

Fleischhacker W, Arango C, Arteel P, Barnes T, Carpenter W, Duckworth K . Schizophrenia--time to commit to policy change. Schizophr Bull. 2014; 40 Suppl 3:S165-94. PMC: 4002061. DOI: 10.1093/schbul/sbu006. View

16.

Karisetty B, Joshi P, Kumar A, Chakravarty S . Sex differences in the effect of chronic mild stress on mouse prefrontal cortical BDNF levels: A role of major ovarian hormones. Neuroscience. 2017; 356:89-101. DOI: 10.1016/j.neuroscience.2017.05.020. View

17.

Zhu X, Xu X, Xu C, Zhang J, Zhang X, Ma L . The interactive effects of stress and coping style on cognitive function in patients with schizophrenia. Neuropsychiatr Dis Treat. 2019; 15:523-530. PMC: 6391124. DOI: 10.2147/NDT.S181471. View

18.

Riecher-Rossler A . Oestrogens, prolactin, hypothalamic-pituitary-gonadal axis, and schizophrenic psychoses. Lancet Psychiatry. 2016; 4(1):63-72. DOI: 10.1016/S2215-0366(16)30379-0. View

19.

Margulska A, Kozlowska E, Wysokinski A . Effect of clozapine dose and concentration on fasting concentration of appetite regulating peptides. Psychiatry Res. 2017; 260:473-477. DOI: 10.1016/j.psychres.2017.12.018. View

20.

Lieberman J, Phillips M, Gu H, Stroup S, Zhang P, Kong L . Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine. Neuropsychopharmacology. 2003; 28(5):995-1003. DOI: 10.1038/sj.npp.1300157. View